Brainstorm Cell Therapeutics (BCLI) Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, Dec. 26, 2023 /PRNewswire/ Brainstorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today provided an update on the grant.
BrainStorm Cell stock spikes on patent wins (NASDAQ:BCLI) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Brainstorm Cell Therapeutics (BCLI) Announces Outcome of FDA Meeting on NurOwn in ALS streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Meeting Provided a Clear Path for Planned Phase 3b Trial
NEW YORK, Dec. 7, 2023 /PRNewswire/ BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for.